These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39058886)

  • 41. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients.
    Karakoyun I; Colak A; Turken M; Altin Z; Arslan FD; Iyilikci V; Yilmaz N; Kose S
    Int Immunopharmacol; 2021 Feb; 91():107285. PubMed ID: 33348293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count.
    Skogmar S; Schön T; Balcha TT; Sturegård E; Jansson M; Björkman P
    PLoS One; 2015; 10(12):e0144292. PubMed ID: 26630153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic and early prognostic value of serum CRP and LDH levels in patients with possible COVID-19 at the first admission.
    Akdogan D; Guzel M; Tosun D; Akpinar O
    J Infect Dev Ctries; 2021 Jun; 15(6):766-772. PubMed ID: 34242184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
    Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
    Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?
    Vaira LA; De Vito A; Deiana G; Pes C; Giovanditto F; Fiore V; Lechien JR; Saussez S; Policicchio D; Boccaletti R; Madeddu G; Babudieri S; Pazzola A; Bandiera F; Fois AG; Piana AF; Hopkins C; De Riu G
    J Laryngol Otol; 2021 Aug; 135(8):723-728. PubMed ID: 34184623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics, anti-SARS-CoV-2 IgG titers, and inflammatory markers in individuals with post-COVID-19 condition in Kenya: a cross-sectional study.
    Theuri M; Ndombi EM; Thamaini P; Ogutu JO; Onsongo L; Madete JK; Ofula V; Gitau S; Mwangi G; Okemo P
    PeerJ; 2024; 12():e17723. PubMed ID: 39056056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delta neutrophil index and C-reactive protein: a potential diagnostic marker of multisystem inflammatory syndrome in children (MIS-C) with COVID-19.
    Karagol C; Tehci AK; Gungor A; Ekici Tekin Z; Çelikel E; Aydın F; Kurt T; Sezer M; Tekgöz N; Coşkun S; Kaplan MM; Bayhan GI; Yaralı HN; Ozbek NY; Çelikel Acar B
    Eur J Pediatr; 2022 Feb; 181(2):775-781. PubMed ID: 34647164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
    Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients.
    Erdogan A; Can FE; Gönüllü H
    J Med Virol; 2021 Sep; 93(9):5555-5559. PubMed ID: 34019701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The asynchronous dynamic changes and interrelationships between leukocyte composition and inflammatory markers and potential clinical significance in the early stage and sepsis stage in severe burns.
    Zhi L; Wang X; Pan X; Han C
    Burns; 2024 Sep; 50(7):1752-1761. PubMed ID: 38724345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers.
    Firoz CK; Jabir NR; Kamal MA; Alama MN; Damanhouri GA; Khan W; Alzahrani AS; Almehdar HA; Tabrez S
    IUBMB Life; 2015 Jun; 67(6):453-9. PubMed ID: 26086324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The roles of a novel inflammatory neopterin in subjects with coronary atherosclerotic heart disease.
    Lyu Y; Jiang X; Dai W
    Int Immunopharmacol; 2015 Feb; 24(2):169-172. PubMed ID: 25479720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Essential metals, vitamins and antioxidant enzyme activities in COVID-19 patients and their potential associations with the disease severity.
    Al-Saleh I; Alrushud N; Alnuwaysir H; Elkhatib R; Shoukri M; Aldayel F; Bakheet R; Almozaini M
    Biometals; 2022 Feb; 35(1):125-145. PubMed ID: 34993712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study.
    Zhang N; Zhang H; Tang Y; Zhang H; Ma A; Xu F; Sun Y; Jiang L; Shan F
    Int J Med Sci; 2021; 18(4):921-928. PubMed ID: 33456349
    [No Abstract]   [Full Text] [Related]  

  • 58. Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?
    Kutluana U; Kilciler AG; Mizrak S; Dilli U
    Gastroenterol Hepatol; 2019 May; 42(5):289-295. PubMed ID: 30795853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.
    Bennouar S; Bachir Cherif A; Kessira A; Hamel H; Boudahdir A; Bouamra A; Bennouar D; Abdi S
    Scand J Clin Lab Invest; 2020 Dec; 80(8):611-618. PubMed ID: 32945705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neopterin: laboratory marker of cellular immunity activation in rheumatoid arthritis].
    Nasonov EL; Samsonov MIu; Chichasova NV; Imametdinova GR; Nikiforova EL; Aleksandrova EN; Ilich-Stoyanovich O; Fux D; Vaxter H
    Ter Arkh; 1998; 70(5):28-31. PubMed ID: 9644738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.